Akcea Therapeutics, Inc

(NASDAQ:AKCA)

Latest On Akcea Therapeutics, Inc (AKCA):

Date/Time Type Description Signal Details
2020-11-04 22:11 ESTNewsPfizer launches Phase 2b vupanorsen study in patients with elevated cholesterol levelN/A
2020-11-01 16:55 ESTFinancialsCompany financials have been released.Neutral
2020-10-14 16:31 ESTInsider TradeIONIS PHARMACEUTICALS INC has indirectly acquired of 21,237,715 shares.Buy
2020-10-13 12:04 ESTAnalyst RatingThe Analyst Target Price has increased from $23.33 to $28.5.Buy
2020-10-13 01:51 ESTNewsIonis Pharmaceuticals acquires Akcea TherapeuticsN/A
2020-09-26 04:07 ESTFinancialsCompany financials have been released.Neutral
2020-09-24 16:30 ESTInsider TradeDamien McDevitt has directly disposed of 8,709 shares and currently holds 242,978 shares.Sell
2020-09-24 16:30 ESTInsider TradeKyle Jenne has directly disposed of 720 shares and currently holds 52,012 shares.Sell
2020-09-24 16:30 ESTInsider TradeJoshua F. Patterson has directly disposed of 319 shares and currently holds 26,532 shares.Sell
2020-09-19 05:11 ESTNewsAkcea's Waylivra secures NICE recommendation for ultra-rare inherited disorderN/A
2020-09-03 13:33 ESTNewsIonis up after cardio-renal pipeline updateN/A
2020-09-02 16:30 ESTInsider TradeDamien McDevitt has directly acquired 1,104 shares and currently holds 251,687 shares.Buy
2020-09-01 12:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $27 to $23.33.Neutral
2020-09-01 01:37 ESTNewsAkcea shoots up 59% after Ionis acquires remaining stake for $500M; positive vupanorsen data reportedN/A
2020-08-13 10:42 ESTNewsNew reimbursement set in Germany for Akcea's WaylivraN/A
2020-08-08 08:04 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 12:05 ESTAnalyst RatingThe Analyst Target Price has decreased from $29 to $27.Neutral
2020-08-07 08:04 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 09:43 ESTNewsAkcea Therapeutics, Inc. 2020 Q2 - Results - Earnings Call PresentationN/A
2020-08-05 06:48 ESTNewsAkcea Therapeutics EPS misses by $0.14, misses on revenueN/A
2020-08-05 06:48 ESTNewsAkcea Therapeutics, Inc. (AKCA) CEO Damien McDevitt on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-04 06:32 ESTNewsAkcea Therapeutics Q2 Earnings PreviewN/A
2020-07-31 00:05 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 15:45 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:10 ESTFinancialsCompany financials have been released.Neutral
2020-07-22 13:56 ESTNewsReimbursement for Akcea's Tegsedi OK'd in AustriaN/A
2020-07-20 18:00 ESTInsider TradeJoshua F. Patterson has directly disposed of 263 shares and currently holds 26,851 shares.Sell
2020-07-15 18:03 ESTInsider TradeWilliam T. Andrews has directly acquired 37,500 shares and currently holds 37,500 shares.Buy
2020-06-13 12:22 ESTNewsAkcea: Uninteresting Slow Growth Stock With Long-Term PotentialN/A
2020-06-08 12:14 ESTNewsAkcea's Tegsedi nabs reimbursement in ItalyN/A
2020-06-02 08:04 ESTEarnings EstimateAn EPS average of -$0.40 is estimated for the quarter ending on September 30, 2020.Buy
2020-06-02 08:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $30 to $29.Neutral
2020-06-01 18:24 ESTNewsAkcea's Tegsedi approved for reimbursement in PortugalN/A
2020-05-28 11:06 ESTNewsAkcea's Tegsedi shows sustained benefit in hATTR extension studyN/A
2020-05-19 18:15 ESTInsider TradeMICHAEL DENNIS PRICE has directly acquired 50,000 shares and currently holds 50,000 shares.Buy
2020-05-19 15:23 ESTNewsNew finance chief at Akcea TherapeuticsN/A
2020-05-15 16:39 ESTNewsAkcea secures reimburse in Spain for TegsediN/A
2020-05-14 11:51 ESTNewsAkcea closing in on reimbursement of Tegsedi in CanadaN/A
2020-05-09 01:56 ESTNewsAkcea Therapeutics, Inc. 2020 Q1 - Results - Earnings Call PresentationN/A
2020-05-08 05:42 ESTNewsAkcea Therapeutics Q1 2020 Earnings PreviewN/A
2020-05-08 05:39 ESTNewsAkcea Therapeutics EPS beats by $0.04, misses on revenueN/A
2020-05-08 05:38 ESTNewsAkcea Therapeutics, Inc. (AKCA) CEO Damien McDevitt on Q1 2020 Results - Earnings Call TranscriptN/A
2020-05-08 00:05 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 08:04 ESTFinancialsCompany financials have been released.Neutral
2020-04-15 18:00 ESTInsider TradeJoshua F. Patterson has directly acquired 12,500 shares and currently holds 27,114 shares.Buy
2020-04-11 00:31 ESTNewsAkcea Therapeutics Q4 Earnings PreviewN/A
2020-04-11 00:29 ESTNewsAkcea Therapeutics EPS beats by $0.41, beats on revenueN/A
2020-04-10 16:31 ESTNewsNew CEO at Akcea TherapeuticsN/A
2020-04-08 04:05 ESTFinancialsCompany financials have been released.Neutral
2020-04-08 00:05 ESTFinancialsCompany financials have been released.Neutral

About Akcea Therapeutics, Inc (AKCA):

Akcea Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines to treat patients with serious and rare diseases in the United States and internationally. The company offers TEGSEDI, an antisense medicine designed to reduce the production of transthyretin protein. It develops WAYLIVRA, which has completed Phase III clinical study for the treatment of familial chylomicronemia syndrome, as well as is in Phase III clinical study for the treatment of familial partial lipodystrophy. The company also develops AKCEA-APO(a)-LRx, which has completed Phase IIb clinical study for treating hyperlipoproteinemia; AKCEA-ANGPTL3-LRx that has completed Phase IIb clinical study for the treatment of homozygous familial hypercholesterolemia; and AKCEA-APOCIII-LRx, which is in Phase II study for the treatment of cardiovascular disease due to elevated triglyceride levels, as well as AKCEA-TTR-LRx to treat the broad population of patients with hereditary and wild-type forms of transthyretin amyloidosis. It has strategic collaboration with Novartis Pharma AG and PTC Therapeutics International Limited. The company was incorporated in 2014 and is headquartered in Boston, Massachusetts. Akcea Therapeutics, Inc. is a subsidiary of Ionis Pharmaceuticals, Inc.

AKCA Quotes by TradingView

See Advanced Chart

General

  • Name Akcea Therapeutics, Inc
  • Symbol AKCA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 294
  • Fiscal Year EndDecember
  • IPO Date2017-07-14
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.akceatx.com
View More

Valuation

  • Trailing PE 39.91
  • Price/Sales (Trailing 12 Mt.) 5.41
  • Price/Book (Most Recent Quarter) 3.85
  • Enterprise Value Revenue 4.37
  • Enterprise Value EBITDA 24.24
View More

Financials

  • Most Recent Quarter 2020-06-30
  • Next Quarter EPS Estimate -$0.40
  • Profit Margin -12%
  • Operating Margin -14%
  • Return on Assets -6%
  • Revenue 336.56 million
  • Earnings Per Share $0.29
  • Revenue Per Share $3.45
  • Gross Profit 185.72 million
  • Quarterly Earnings Growth -15.9%
View More

Highlights

  • Market Capitalization 1.85 billion
  • EBITDA 44.73 million
  • Analyst Target Price $28.5
  • Book Value Per Share $4.72
View More

Share Statistics

  • Shares Outstanding 101.62 million
  • Shares Float 17.9 million
  • % Held by Insiders 8288%
  • % Held by Institutions 20.84%
  • Shares Short 759276
  • Shares Short Prior Month 1.17 million
  • Short Ratio 0.68
  • Short % of Float 6%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 1.44
  • 52 Week High $21.71
  • 52 Week Low $8
  • 50 Day Moving Average 18.14
  • 200 Day Moving Average 14.85
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Akcea Therapeutics, Inc (AKCA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Akcea Therapeutics, Inc (AKCA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-06-302020-08-04$N/A-$0.49-$0.35-40%
2020-03-312020-05-05$16.07 million-$0.42-$0.468.7%
2019-12-312020-02-25$277.48 million$0.86$1.11-22.52%
2019-09-302019-11-05$20.62 million-$0.34-$0.4727.66%
2019-06-302019-08-07$26.62 million-$0.40-$0.436.98%
2019-03-312019-05-08$163.82 million$0.29$0.98-70.41%
2018-12-312019-02-26$10.2 million-$0.79-$0.73-8.22%
2018-09-302018-11-05$19.24 million-$0.73-$0.808.75%
2018-06-302018-08-06$18.32 million-$0.75-$1.2439.52%
2018-03-312018-05-03$17.11 million-$0.44-$0.36-22.22%
2017-12-312018-02-26$18.04 million-$0.27-$0.21-28.57%
2017-09-302017-11-06$9.91 million-$0.18-$0.180%
2017-06-302017-07-14$5.71 million-$0.41

Akcea Therapeutics, Inc (AKCA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019
Research Development N/A 17.36 million 292.85 million 24.8 million 20.27 million
Income Before Tax N/A -43.62 million 84.05 million -31.24 million -37.16 million
Selling General Administrative N/A 46.25 million 51.43 million 34.91 million 50.74 million
Gross Profit N/A 11.29 million 412.88 million 18.22 million 1.99 million
Ebit N/A -45.26 million 83.16 million -32.59 million -38.71 million
Operating Income N/A -45.26 million 83.16 million -32.59 million -38.71 million
Income Tax Expense -605000 -768000 1.64 million 259000 160000
Total Revenue N/A 16.07 million 277.48 million 20.62 million 26.62 million
Cost of Revenue N/A 4.78 million -135.4 million 2.4 million 24.64 million
Total Other Income Expense Net N/A 1.64 million 884000 1.35 million 1.54 million
Net Income From Continuing Operations N/A -42.85 million 82.41 million -31.5 million -37.32 million
Net Income Applicable to Common Shares -49.58 million -42.85 million 82.41 million -31.5 million -37.32 million
Cash Flow:
Date Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019
Investments N/A N/A N/A N/A -24.39 million
Change to Liabilities -6.73 million N/A N/A N/A -5.65 million
Total Cash Flow from Investing Activities 4.07 million N/A N/A N/A -24.75 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A N/A N/A 2.82 million
Change to Operating Activities 8.27 million N/A N/A N/A 942000
Change in Cash N/A N/A N/A N/A -50.79 million
Total Cash from Operating Activities -33.42 million N/A N/A N/A -28.77 million
Depreciation N/A N/A N/A N/A 2.16 million
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A -4.01 million
Change to Account Receivables N/A N/A N/A N/A 1.08 million
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 16.56 million N/A N/A N/A 14.16 million
Capital Expenditures N/A N/A N/A N/A 358000
Balance Sheet:
Date Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019
Total Liabailities N/A N/A 56.25 million 57.68 million 65.48 million
Total Stockholder Equity N/A N/A 543 million 325.49 million 368.64 million
Other Current Liabilities N/A N/A 4.8 million 12.82 million 16.27 million
Total Assets N/A N/A 599.25 million 383.17 million 434.12 million
Common Stock 479.03 million 509.69 million 543 million 325.49 million 93000
Other Current Assets N/A N/A 10.69 million 5.81 million 6.71 million
Retained Earnings N/A N/A N/A N/A -532.18 million
Other Liabilities 183000 N/A N/A N/A N/A
Other Assets 3.1 million 3.08 million 2.94 million 3.62 million 3.43 million
Cash N/A N/A 306.87 million 129.33 million 150.23 million
Total Current Liabilities N/A N/A 42 million 43.12 million 50.57 million
Other Stockholder Equity N/A N/A N/A N/A -110000
Property, Plant & Equipment 16.54 million 16.31 million 16.36 million 16.58 million 16.98 million
Total Current Assets N/A N/A 496.91 million 278.44 million 327.71 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 398.9 million 428.1 million 459.95 million 240.96 million 282.64 million
Short Term Investments N/A N/A 156.81 million 123.36 million 145.37 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A 8.82 million 8.64 million 8.29 million
Accounts Payable N/A N/A 10.22 million 5.71 million 7.94 million

Akcea Therapeutics, Inc (AKCA) Chart:

Akcea Therapeutics, Inc (AKCA) News:

Below you will find a list of latest news for Akcea Therapeutics, Inc (AKCA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Akcea Therapeutics, Inc (AKCA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Akcea Therapeutics, Inc (AKCA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520174060/0001193125-20-174060-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1662524/000031506619000840/0000315066-19-000840-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1662524/000031506620000803/0000315066-20-000803-index.htm
2020-10-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1662524/000031506620001814/0000315066-20-001814-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000089924320028167/0000899243-20-028167-index.htm
2018-06-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1662524/000110465918041089/0001104659-18-041089-index.htm
2018-08-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1662524/000110465918049912/0001104659-18-049912-index.htm
2018-10-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1662524/000110465918063351/0001104659-18-063351-index.htm
2019-04-02SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1662524/000110465919019394/0001104659-19-019394-index.htm
2019-12-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1662524/000110465919074467/0001104659-19-074467-index.htm
2018-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000114036118027358/0001140361-18-027358-index.htm
2018-07-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000114036118032207/0001140361-18-032207-index.htm
2018-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000114036118034994/0001140361-18-034994-index.htm
2018-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000114036118035588/0001140361-18-035588-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1662524/000114036118035801/0001140361-18-035801-index.htm
2018-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000114036118037026/0001140361-18-037026-index.htm
2018-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000114036118037945/0001140361-18-037945-index.htm
2018-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000114036118038675/0001140361-18-038675-index.htm
2018-09-18S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1662524/000114036118038676/0001140361-18-038676-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000114036118040212/0001140361-18-040212-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000114036118040237/0001140361-18-040237-index.htm
2018-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312518318386/0001193125-18-318386-index.htm
2018-11-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312518333127/0001193125-18-333127-index.htm
2018-11-28DEF 14COther definitive information statementshttps://www.sec.gov/Archives/edgar/data/1662524/000119312518336600/0001193125-18-336600-index.htm
2018-12-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1662524/000119312518356321/0001193125-18-356321-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519048914/0001193125-19-048914-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519051972/0001193125-19-051972-index.htm
2019-04-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519122450/0001193125-19-122450-index.htm
2019-04-29DEF 14COther definitive information statementshttps://www.sec.gov/Archives/edgar/data/1662524/000119312519123848/0001193125-19-123848-index.htm
2019-04-29DEFA14CAdditional information statement materials, definitivehttps://www.sec.gov/Archives/edgar/data/1662524/000119312519123859/0001193125-19-123859-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519141426/0001193125-19-141426-index.htm
2019-05-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1662524/000119312519151786/0001193125-19-151786-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519214084/0001193125-19-214084-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519251267/0001193125-19-251267-index.htm
2019-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519264471/0001193125-19-264471-index.htm
2019-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519269330/0001193125-19-269330-index.htm
2019-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519272080/0001193125-19-272080-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519284723/0001193125-19-284723-index.htm
2019-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519305731/0001193125-19-305731-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519315200/0001193125-19-315200-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312519318230/0001193125-19-318230-index.htm
2020-01-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520001733/0001193125-20-001733-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520005423/0001193125-20-005423-index.htm
2020-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520011478/0001193125-20-011478-index.htm
2020-01-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520016998/0001193125-20-016998-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520034237/0001193125-20-034237-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520048362/0001193125-20-048362-index.htm
2020-03-04DEF 14COther definitive information statementshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520061635/0001193125-20-061635-index.htm
2020-03-04DEFA14CAdditional information statement materials, definitivehttps://www.sec.gov/Archives/edgar/data/1662524/000119312520061683/0001193125-20-061683-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520061706/0001193125-20-061706-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520069633/0001193125-20-069633-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520080680/0001193125-20-080680-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520083194/0001193125-20-083194-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520102014/0001193125-20-102014-index.htm
2020-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520126287/0001193125-20-126287-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520133725/0001193125-20-133725-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520144519/0001193125-20-144519-index.htm
2020-05-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520148663/0001193125-20-148663-index.htm
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520174060/0001193125-20-174060-index.htm
2020-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520190078/0001193125-20-190078-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520209319/0001193125-20-209319-index.htm
2020-08-31SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1662524/000119312520235410/0001193125-20-235410-index.htm
2020-08-31SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1662524/000119312520235414/0001193125-20-235414-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520236382/0001193125-20-236382-index.htm
2020-08-31SC14D9CWritten communication relating to third party tender offerhttps://www.sec.gov/Archives/edgar/data/1662524/000119312520236386/0001193125-20-236386-index.htm
2020-08-31SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1662524/000119312520236406/0001193125-20-236406-index.htm
2020-09-01SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1662524/000119312520237229/0001193125-20-237229-index.htm
2020-09-01SC14D9CWritten communication relating to third party tender offerhttps://www.sec.gov/Archives/edgar/data/1662524/000119312520237302/0001193125-20-237302-index.htm
2020-09-14SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1662524/000119312520245290/0001193125-20-245290-index.htm
2020-09-14SC 14D9Solicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520245314/0001193125-20-245314-index.htm
2020-09-15SC 13E3Going private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1662524/000119312520245549/0001193125-20-245549-index.htm
2020-09-15SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520246309/0001193125-20-246309-index.htm
2020-09-24SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1662524/000119312520253520/0001193125-20-253520-index.htm
2020-09-24SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520253525/0001193125-20-253525-index.htm
2020-09-24SC 13E3/AGoing private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1662524/000119312520253529/0001193125-20-253529-index.htm
2020-09-29SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1662524/000119312520257914/0001193125-20-257914-index.htm
2020-09-29SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520257975/0001193125-20-257975-index.htm
2020-09-29SC 13E3/AGoing private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1662524/000119312520257979/0001193125-20-257979-index.htm
2020-09-30SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1662524/000119312520259719/0001193125-20-259719-index.htm
2020-09-30SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520259817/0001193125-20-259817-index.htm
2020-09-30SC 13E3/AGoing private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1662524/000119312520259878/0001193125-20-259878-index.htm
2020-10-02SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520262654/0001193125-20-262654-index.htm
2020-10-02SC 13E3/AGoing private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1662524/000119312520262664/0001193125-20-262664-index.htm
2020-10-02SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1662524/000119312520262669/0001193125-20-262669-index.htm
2020-10-13SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1662524/000119312520268013/0001193125-20-268013-index.htm
2020-10-13SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520268015/0001193125-20-268015-index.htm
2020-10-13SC 13E3/AGoing private transaction by certain issuershttps://www.sec.gov/Archives/edgar/data/1662524/000119312520268016/0001193125-20-268016-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662524/000119312520268019/0001193125-20-268019-index.htm
2020-10-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1662524/000119312520268022/0001193125-20-268022-index.htm
2020-10-13POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1662524/000119312520268025/0001193125-20-268025-index.htm
2020-10-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520268028/0001193125-20-268028-index.htm
2020-10-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520268031/0001193125-20-268031-index.htm
2020-10-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520268033/0001193125-20-268033-index.htm
2020-10-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520268034/0001193125-20-268034-index.htm
2020-10-13S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1662524/000119312520268035/0001193125-20-268035-index.htm
2020-10-2315-12BSecurities registration termination [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1662524/000119312520274919/0001193125-20-274919-index.htm
2018-06-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919118035587/0001209191-18-035587-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919118035589/0001209191-18-035589-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919118035591/0001209191-18-035591-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919118035596/0001209191-18-035596-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919118035603/0001209191-18-035603-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919118035612/0001209191-18-035612-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919118039861/0001209191-18-039861-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919118040492/0001209191-18-040492-index.htm
2018-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919118045573/0001209191-18-045573-index.htm
2018-10-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919118054760/0001209191-18-054760-index.htm
2018-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919118055607/0001209191-18-055607-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119002133/0001209191-19-002133-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119002136/0001209191-19-002136-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119002139/0001209191-19-002139-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119002143/0001209191-19-002143-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119002148/0001209191-19-002148-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119017835/0001209191-19-017835-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119022439/0001209191-19-022439-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119024175/0001209191-19-024175-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119024176/0001209191-19-024176-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119037695/0001209191-19-037695-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119037700/0001209191-19-037700-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119037709/0001209191-19-037709-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119037713/0001209191-19-037713-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119037715/0001209191-19-037715-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119037721/0001209191-19-037721-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119041109/0001209191-19-041109-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119041123/0001209191-19-041123-index.htm
2019-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119042401/0001209191-19-042401-index.htm
2019-09-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119050456/0001209191-19-050456-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119050457/0001209191-19-050457-index.htm
2019-09-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119050473/0001209191-19-050473-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119050475/0001209191-19-050475-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119050481/0001209191-19-050481-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119050482/0001209191-19-050482-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119050494/0001209191-19-050494-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119051139/0001209191-19-051139-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119051167/0001209191-19-051167-index.htm
2019-10-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119053840/0001209191-19-053840-index.htm
2019-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119053841/0001209191-19-053841-index.htm
2019-12-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119059034/0001209191-19-059034-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119059037/0001209191-19-059037-index.htm
2019-12-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119060660/0001209191-19-060660-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119060662/0001209191-19-060662-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919119061304/0001209191-19-061304-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120001230/0001209191-20-001230-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120001242/0001209191-20-001242-index.htm
2020-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120003752/0001209191-20-003752-index.htm
2020-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120003753/0001209191-20-003753-index.htm
2020-02-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120009262/0001209191-20-009262-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120009267/0001209191-20-009267-index.htm
2020-03-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120019248/0001209191-20-019248-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120020632/0001209191-20-020632-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120020637/0001209191-20-020637-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120020642/0001209191-20-020642-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120020643/0001209191-20-020643-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120020647/0001209191-20-020647-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120021118/0001209191-20-021118-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120021120/0001209191-20-021120-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120021122/0001209191-20-021122-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120021123/0001209191-20-021123-index.htm
2020-03-314/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120021951/0001209191-20-021951-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120024496/0001209191-20-024496-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120024500/0001209191-20-024500-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120024502/0001209191-20-024502-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120024503/0001209191-20-024503-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120024505/0001209191-20-024505-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120024507/0001209191-20-024507-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120024510/0001209191-20-024510-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120024511/0001209191-20-024511-index.htm
2020-05-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120030616/0001209191-20-030616-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120030621/0001209191-20-030621-index.htm
2020-07-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120042199/0001209191-20-042199-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120042203/0001209191-20-042203-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120043062/0001209191-20-043062-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120049120/0001209191-20-049120-index.htm
2020-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120051888/0001209191-20-051888-index.htm
2020-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120051891/0001209191-20-051891-index.htm
2020-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120051894/0001209191-20-051894-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054604/0001209191-20-054604-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054607/0001209191-20-054607-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054608/0001209191-20-054608-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054609/0001209191-20-054609-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054610/0001209191-20-054610-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054611/0001209191-20-054611-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054612/0001209191-20-054612-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054613/0001209191-20-054613-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054614/0001209191-20-054614-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054615/0001209191-20-054615-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054616/0001209191-20-054616-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054618/0001209191-20-054618-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662524/000120919120054622/0001209191-20-054622-index.htm
2020-10-1325-NSENotification filed by national security exchange to report the removal from listing and registration of matured, redeemed or rethttps://www.sec.gov/Archives/edgar/data/1662524/000135445720000579/0001354457-20-000579-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1662524/000156459018027289/0001564590-18-027289-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1662524/000156459019005745/0001564590-19-005745-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1662524/000156459019018117/0001564590-19-018117-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1662524/000156459019029968/0001564590-19-029968-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1662524/000156459019040897/0001564590-19-040897-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1662524/000156459020008119/0001564590-20-008119-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1662524/000156459020021896/0001564590-20-021896-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1662524/000156459020036729/0001564590-20-036729-index.htm
2018-12-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1662524/999999999718009600/9999999997-18-009600-index.htm
2019-06-05CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1662524/999999999719005357/9999999997-19-005357-index.htm
2020-09-21CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1662524/999999999720004695/9999999997-20-004695-index.htm
2020-09-21CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1662524/999999999720004696/9999999997-20-004696-index.htm

Akcea Therapeutics, Inc (AKCA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Akcea Therapeutics, Inc (AKCA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 8288%
Institutional Ownership: 2084%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-03-06Paula SoteropoulosChief Executive OfficerSell18,386.0032.14590,856.170.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119017835/0001209191-19-017835-index.htm
2019-04-05Paula SoteropoulosChief Executive OfficerSell30,000.0032.11963,300.000.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119024175/0001209191-19-024175-index.htm
2019-04-08Paula SoteropoulosChief Executive OfficerSell1,787.0032.1757,480.280.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119024175/0001209191-19-024175-index.htm
2020-03-23Joshua F. PattersonGeneral CounselSell335.0011.763,938.0914,614.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120021123/0001209191-20-021123-index.htm
2020-03-19Joshua F. PattersonGeneral CounselBuy3,780.0014,949.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120020637/0001209191-20-020637-index.htm
2019-09-26Paula SoteropoulosChief Executive OfficerBuy1,711,079.006.4811,087,791.921,711,079.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119051139/0001209191-19-051139-index.htm
2019-04-08Paula SoteropoulosChief Executive OfficerBuy1,787.006.4811,579.761,787.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119024175/0001209191-19-024175-index.htm
2019-03-06Paula SoteropoulosChief Executive OfficerBuy18,386.006.48119,141.2818,386.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119017835/0001209191-19-017835-index.htm
2019-09-26Jeff Marc GoldbergChief Operating OfficerBuy35,230.0012.21430,158.30186,647.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119051167/0001209191-19-051167-index.htm
2019-07-15Sarah BoycePresidentSell1,819.0023.5242,782.8819,888.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119042401/0001209191-19-042401-index.htm
2019-09-19Louis O'DeaChief Medical OfficerBuy20,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119050494/0001209191-19-050494-index.htm
2019-09-19Michael F MacLeanChief Financial OfficerBuy20,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119050482/0001209191-19-050482-index.htm
2019-09-19Damien McDevittInterim Chief Executive OfficeBuy200,000.00200,000.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119050481/0001209191-19-050481-index.htm
2019-09-26Jeff Marc GoldbergChief Operating OfficerBuy83,952.006.48544,008.96204,390.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119051167/0001209191-19-051167-index.htm
2019-07-01Sarah BoycePresidentBuy813.0020.0416,294.9621,707.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119041123/0001209191-19-041123-index.htm
2019-04-08Jeff Marc GoldbergChief Operating OfficerBuy20,000.006.48129,600.0022,880.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119024176/0001209191-19-024176-index.htm
2020-09-22Damien McDevittChief Executive OfficerSell8,709.0018.12157,807.08242,978.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120051888/0001209191-20-051888-index.htm
2020-03-23Damien McDevittChief Executive OfficerSell9,417.0011.75110,648.81245,783.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120021118/0001209191-20-021118-index.htm
2020-08-31Damien McDevittChief Executive OfficerBuy1,104.0014.4015,896.50251,687.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120049120/0001209191-20-049120-index.htm
2020-03-19Damien McDevittChief Executive OfficerBuy55,200.00255,200.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120020632/0001209191-20-020632-index.htm
2020-09-22Joshua F. PattersonGeneral CounselSell319.0018.125,780.2826,532.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120051894/0001209191-20-051894-index.htm
2020-07-17Joshua F. PattersonGeneral CounselSell263.0012.503,287.7926,851.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120043062/0001209191-20-043062-index.htm
2020-04-15Joshua F. PattersonGeneral CounselBuy12,500.0027,114.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120024511/0001209191-20-024511-index.htm
2019-04-05Jeff Marc GoldbergChief Operating OfficerSell30,000.0031.71951,300.002,880.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119024176/0001209191-19-024176-index.htm
2019-04-08Jeff Marc GoldbergChief Operating OfficerSell20,000.0031.72634,418.002,880.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119024176/0001209191-19-024176-index.htm
2019-04-05Paula SoteropoulosChief Executive OfficerBuy30,000.006.48194,400.0030,000.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119024175/0001209191-19-024175-index.htm
2019-09-26Jeff Marc GoldbergChief Operating OfficerBuy302,250.006.481,958,580.00305,560.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119051167/0001209191-19-051167-index.htm
2019-04-05Jeff Marc GoldbergChief Operating OfficerBuy30,000.006.48194,400.0032,880.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119024176/0001209191-19-024176-index.htm
2019-07-01Jeff Marc GoldbergChief Operating OfficerBuy430.0020.048,618.493,310.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119041109/0001209191-19-041109-index.htm
2019-10-21Kyle JenneChief Commercial OfficerBuy25,000.0036,711.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119053841/0001209191-19-053841-index.htm
2020-07-09William T. AndrewsChief Medical OfficerBuy37,500.0037,500.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120042203/0001209191-20-042203-index.htm
2020-01-15Louis O'DeaChief Medical OfficerBuy28,000.0048,000.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120003753/0001209191-20-003753-index.htm
2020-01-15Michael F MacLeanChief Financial OfficerBuy28,000.0048,000.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120003752/0001209191-20-003752-index.htm
2019-12-02Alex G. HowarthChief Operating OfficerBuy50,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119059037/0001209191-19-059037-index.htm
2020-05-18MICHAEL DENNIS PRICEChief Financial OfficerBuy50,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120030621/0001209191-20-030621-index.htm
2020-09-22Kyle JenneChief Commercial OfficerSell720.0018.1213,046.4052,012.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120051891/0001209191-20-051891-index.htm
2020-03-23Kyle JenneChief Commercial OfficerSell779.0011.759,153.4852,732.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120021122/0001209191-20-021122-index.htm
2020-03-19Kyle JenneChief Commercial OfficerBuy16,800.0053,511.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120020643/0001209191-20-020643-index.htm
2020-03-23Louis O'DeaChief Medical OfficerSell3,198.0011.7537,578.7461,602.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120021120/0001209191-20-021120-index.htm
2020-03-19Louis O'DeaChief Medical OfficerBuy16,800.0064,800.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120020642/0001209191-20-020642-index.htm
2020-03-19Alex G. HowarthChief Operating OfficerBuy16,800.0066,800.00https://www.sec.gov/Archives/edgar/data/1662524/000120919120020647/0001209191-20-020647-index.htm
2019-09-26Paula SoteropoulosChief Executive OfficerBuy145,303.006.48941,563.44742,890.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119051139/0001209191-19-051139-index.htm
2019-09-26Paula SoteropoulosChief Executive OfficerBuy205,479.0012.212,508,898.59853,213.00https://www.sec.gov/Archives/edgar/data/1662524/000120919119051139/0001209191-19-051139-index.htm
2020-10-10IONIS PHARMACEUTICALS INC10% Share HolderBuy21,237,715.0018.15385,464,527.2598,322,397.00https://www.sec.gov/Archives/edgar/data/1662524/000089924320028167/0000899243-20-028167-index.htm